Register Today!
Registration
Home
Sponsors
|
Program Schedule
Schedule and Invited Speakers at a Glance
Day One: Tuesday, February 20
7:45 – 8:15 AM
|
Registration
|
8:15 – 8:30 AM
|
Welcome and Conference Kick-off
-
Charles Jaffe, MD, PhD, Chief Executive Officer, HL7
-
Ticia Gerber, MHS/HP, Global Director, Partnerships and Policy, HL7
-
Grant Wood, Intermountain Precision Genomics, Intermountain Healthcare; Co-Chair, HL7 Clinical Genomics Workgroup
|
8:30 – 9:00 AM
|
Morning Keynote: Genomics and AI: Opportunities on the Horizon
-
Paul Varghese MD, Head, Health Informatics, Verily (Google) Lifescience
|
9:00 – 9:30 AM
|
Morning Keynote: "Intelligent" Conclusions, Seeing Through the Hype to Find Real Innovation
-
Grant Wood, Intermountain Healthcare
|
9:30 – 10:00 AM
|
New Space, New Technology, New Possibilities: Entrepreneurial Innovation at the Intersection of Artificial Intelligence (AI) and Healthcare
-
Abhi Gholap, Chairman and Co-Founder, OptraHealth
|
10:00 – 10:15 AM
|
Morning Break
|
10:15 – 11:00 AM
|
Collaborative and Network Genomics Initiatives: Healthcare Provider, Patient and Interoperability Impacts (Panel Discussion)
-
Brian Bot, Prinicpal Scientist and Community Manager, Sage Bionetworks
-
Alexandra C. Ehrlich, Principal Solutions Consultant, Oracle Health Sciences
|
11:00 – 12:00 PM
|
Key Policy Issues in National Genomics and Interoperability in the Artificial Intelligence Age
-
Ticia Gerber, MHS/HP, Global Director, Partnerships and Policy, HL7 Moderator
-
Leigh Burchell, Vice President, Government Relations, AllScripts
-
Lauren Riplinger, JD, Senior Director, Federal Relations, AHIMA
-
Mari Savickis, Vice President, Federal Affairs, CHIME
-
Mark J. Segal, PhD, FHIMSS, Principal, Digital Health Advisors, LLC
-
Jeffrey Smith, MPP, Vice President, Public Policy, AMIA
|
12:00 – 1:00 PM
|
Networking Lunch
|
1:00 – 1:30 PM
|
Afternoon Keynote: Use Cases Supported by FHIR Genomics: Innovation, Implementation and Vital Data Sharing
-
Gil Alterovitz, PhD, Assistant Professor, Division of Medical Sciences/Computational Health Informatics, Harvard Medical School/Boston Children's Hospital; Co-Chair, HL7 Clinical Genomics Workgroup
|
1:30 – 2:00 PM
|
Private Sector Innovation and Entrepreneurship in Genomics
-
Julianna Kohler, M.H.S,. Data Science Lead ConvergeHEALTH by Deloitte
|
2:00 - 4:00 PM
|
Interactive Genomics Work Session
Goals and Discussion Topics
Policy Issues
2:00pm – Brainstorm guiding principles and critical policy issues at the intersection of genomics and AI.
Research and Clinical Genomics Applications
2:30pm – Explore most promising, feasible, ideas for Genomics and AI in research and in clinical applications over the next few years; List the issues to tackle in achieving these goals.
Use of FHIR Genomics Standards
3:00pm – Outline steps to optimize use of FHIR Genomics standards in Genomics and AI applications. Identify critical areas to solve existing or future data interoperability requirements.
Critical Data Sets
3:30pm – Identify specific data sets critical for making the analysis of Genomics and AI possible and successful – including data sets that are currently in silos, not currently collected, and that need to be combined; Explore data and other issues to address that will enable required data sharing.
|
Day Two: Wednesday, February 21
|
7:45 – 8:30 AM
|
Registration
|
8:30 AM
|
Welcome, Conference Day Kick-off and Opening Address: FHIR and the Future of Healthcare
-
Charles Jaffe, MD, PhD, Chief Executive Officer, HL7
|
8:30 – 8:45 AM
|
Morning Briefnote: An Overview of the NHGRI 2020 Vision for Genomics
-
Cristina Kapustij, Chief of Policy and Program Analysis, NHGRI
|
8:45 – 9:15 AM
|
Morning Keynote: All of Us National Research Program: Building the Foundation, Setting Future Milestones
-
Bradley Ozenberger, PhD, Program Director, Data Resources and Genomics Platform, All of Us Research Program, Precision Medicine Initiative, National Institutes of Health (NIH), U.S. Department of Health and Human Services
|
9:15 – 10:00 AM
|
Morning Keynote: Progressing Forward: Leveraging the Current Policy and Regulatory Environment for Good
-
Mark J. Segal, PhD, FHIMSS, Principal, Digital Health Advisors, LLC; Chair, Policy Advisory Committee, HL7
|
10:00 – 10:30 AM
|
Morning Keynote: The Future of International Collaboration: Policy and Technology Considerations
-
Peter Goodhand, Director, Global Alliance for Genomics and Health
|
10:30 – 11:00 AM
|
Morning Break
|
11:00 – 11:45 AM
|
Preparing for Tomorrow's Future Today: Scan of Genomics, AI, Informatics and Machine Learning
-
Sam Hanna, MBA, CBCP, CISA, CRISC, Program Director, Masters of Science in Management of Healthcare Informatics and Analytics (MHIA), George Washington University School of Public Health
|
11:45 – 12:30 PM
|
Luncheon Address: The Rise of AI Assist: Genomics + Data Liquidity.
-
Pete Celano, MBA, Director of Consumer Health, MedStar Institute for Innovation
|
12:30 – 3:30 PM
|
Interactive Genomics Work Session
Goals and Discussion Topics
Patient and Healthcare Consumer Applications
12:30 pm – Brainstorm most promising, feasible ideas for Genomics and AI in patient and healthcare consumer applications over the next few years; List the issues to overcome in achieving these goals.
Global Genomics, Public Health and Implementation
1:30 pm – List benefits and issues of Genomics and AI in public health, national genomic initiatives, and global implementation (mostly for LMICs).
Genomics and AI Action Agenda: Key Components and Collaborations
2:00pm – Create a new grassroots coalition that will develop a plan to promote the action agenda, identify key stakeholders and strategic partnerships, and drive new collaborations.
Wrap-up and Next Steps
3:00pm – Review the previous action agenda sessions to finalize the draft document. Identify the important next steps and timeline.
|
|